$50 OFFon all weight loss plans, starting at $139.99/mo

The Science.

A lighter way,
above the clouds.

Our GLP-1 medications work with your body to help you eat less, feel fuller, and lose weight — sustainably.

What is GLP-1?

Your body already knows how.

GLP-1 is a natural hormone that helps regulate appetite, food intake, and blood sugar.

Naturally produced

Born in the gut

GLP-1 is released after you eat. It sends signals to your brain and stomach to help you feel full and satisfied.

But it doesn't last

GLP-1 breaks down in minutes

Your body breaks down natural GLP-1 very quickly — often in less than 2 minutes.

Semaglutide

A long-acting GLP-1 receptor agonist.

It works like your body's natural GLP-1 hormone but is designed to last much longer, supporting appetite regulation throughout the week.

Tirzepatide

Tirzepatide does more.

It activates both GLP-1 and GIP receptors — two powerful hormones that work together to enhance weight loss.

Brain response

Your brain gets the message

These signals help reduce hunger, cravings, and food noise — so you can finally feel in control.

Over time

Real results, real transformation

With consistent use, these medications can help you lose weight, improve health markers, and feel like yourself again.

Never alone in the sky

Physician-guided, every step

Our licensed providers create personalized plans and are with you every step of the way.

Scientific References

GLP-1 Biology

The Physiology of Glucagon-Like Peptide 1. Physiological Reviews. 2007.

Landmark review explaining how GLP-1 is naturally released from the intestine after meals and regulates appetite, gastric emptying, and insulin secretion.

Incretin Hormones: Their Role in Health and Disease. Diabetes, Obesity and Metabolism.

Reviews GLP-1 and GIP physiology, appetite regulation, and glucose homeostasis.

Semaglutide

Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine. 2021.

The pivotal STEP 1 trial showing significant weight loss with once-weekly semaglutide combined with lifestyle intervention.

Semaglutide Treatment Effect in People with Obesity (STEP) Clinical Trial Program.

Collection of pivotal studies demonstrating semaglutide's effects on weight management across diverse patient populations.

Tirzepatide

Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine. 2022.

Landmark trial demonstrating substantial weight reduction with tirzepatide in adults with obesity or overweight.

The Role of Dual GIP and GLP-1 Receptor Agonism in Treating Type 2 Diabetes.

Reviews how tirzepatide activates both GLP-1 and GIP receptors and the scientific rationale behind dual agonism.

Semaglutide vs. Tirzepatide

Tirzepatide as Compared with Semaglutide for the Treatment of Obesity. New England Journal of Medicine. 2025.

Head-to-head trial comparing tirzepatide with semaglutide for obesity treatment, demonstrating greater average weight loss with tirzepatide under the study conditions.

GLP-1 Mechanisms

Central Nervous System Control of Food Intake by GLP-1.

Reviews how GLP-1 signaling acts on the brain to reduce hunger, increase satiety, and decrease food intake.

The information on this page is provided for educational purposes only and is not intended as medical advice or a substitute for evaluation by a licensed healthcare provider. Individual results vary, and not everyone is a candidate for GLP-1 treatment. All prescription medications are provided only after a licensed clinician determines they are medically appropriate.

Compounded medications are not reviewed or approved by the U.S. Food and Drug Administration (FDA). Compounded drugs are prepared by licensed compounding pharmacies to meet individual patient needs when prescribed by a licensed healthcare provider.